PTX

0.00%

3.9¢ prescient therapeutics limited

Live Investor briefing, page-18

First 18 Last

Share
Profile

Follow
mrdingo

4,431 Posts.

1261

08/02/23

10:35

Post #: 66131468
Share

Originally posted by dalts66: ↑

Gday Shell. Isn't investing in this end of the market exciting? I love it

Keep on doing what you are doing. Keep up to date with what the company says it's going to do versus what it is achieving. Keep an eye on any competition drugs. Keep an eye on the companies money in the bank vs. expenditure. Compare market cap with peers (probably the hardest bit)

PTX has a pretty exciting and diverse pipeline. Big picture I think of the pipeline as being PTX100, PTX200, and Omnicar. I include the cell tech into the omnicar basket as it hasnt hit an arm yet.

Individually, PTX 100 and 200 have shown solid clinical response (with a few CRs attached to PTX200). Omicar, with its potential to control drug dosing over a wide spectrum of treatment, holds lots of potential.

So looking at peers and past drug development company evolution, an EV of $50 million for each bit of that pipeline wouldn't seem out of the ballpark. (current market conditions excluded, I am looking longer term). So, a fair value of $150 market cap. PTX is sub $80 million at the moment.

So, as long as there is no negative DD that could cause that difference, PTX is a long-term hold to buy for me. I grabbed as many of those cheapies as I could yesterday. I have converted 1.28 million options (hopefully actioned this week) and will convert the rest before the end of the month. I grabbed some more OCs yesterday when they discounted to heads.

The difference between real market cap vs fair value is how I determine to buy sell or hold. I will take some profit if it trades above whete I think it should be, I buy more when its below where I think it should be. Charts help refine the price.

Expand

"Isn't investing in this end of the market exciting?"

Jeez @dalts66, I reckon i could use a few different adjectives to discribe the market at the moment.

PTX Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

There are more pages in this discussion • 64 more messages in this thread...

First 18 Last

Add PTX (ASX) to my watchlist

(20min delay)
Last 3.9¢		Change 0.000(0.00%)		Mkt cap ! $31.40M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.8¢	$16.31K	421.6K

Buyers (Bids)

No.	Vol.	Price($)
1	47849	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	73928	2

View Market Depth

No.	Vol.	Price($)
1	47849	0.039
5	707297	0.038
8	387500	0.037
5	708916	0.036
3	253590	0.035

Price($)	Vol.	No.
0.040	73928	2
0.041	200000	2
0.042	499154	4
0.043	449950	2
0.045	217151	3

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PTX (ASX) Chart

Live Investor briefing, page-18

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Live Investor briefing, page-18

Top Stories

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News